Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
mark2802 schreef op 22 juni 2021 07:54 :
Iemand enig idee hoelaat de cijfers komen?
om 8 uur
Preliminary Results for the year ended 31 March 2021 June 22, 2021 PROFITABILITY PROGRESSION AND STRATEGIC PROGRESS Accsys today announces its preliminary results for the year ended 31 March 2021 (“FY 21”). Year to 31 March 2021 Year to 31 March 2020 Underlying Statutory Underlying Statutory Total Group Revenue €99.8m €99.8 €90.9 €€94.1 Gross profit €33.1m €33.1m €27.5m €30.7m EBITDA2 €10.1m €10.4m €7.0m €10.0m EBIT3 €4.4m €4.6m €1.4m €4.4m Profit/(loss) before tax €1.1m €0.3m (€2.2m) €1.5m Period end net (debt) (€12.2m) (€25.2m) Accoya® sales volume 60,566m3 57,842m3 KEY HIGHLIGHTS: Revenue up 10% and sales volumes up 4.5% with a rapid recovery after the initial impact of COVID-19 in the first quarter. Strong profitability progression: Group underlying EBITDA2 up 44% to €10.1m and Accoya® Manufacturing margin1 up 340bps to 33.4%, driven by higher sales prices. Our second consecutive year of positive EBIT. Accoya® performance drove a 61% increase in Group Operating cashflow5, with continuing significant market demand in excess of production capacity. Robust balance sheet with €13.0m reduction in Group Net Debt4 with strong Accoya® cash generation. Strategic progress towards 2025 target of increasing production capacity five-fold6: World-first Tricoya® (Hull) plant construction in final stages of completion despite ongoing challenges. The Group is taking over the project and is evaluating the most effective way to complete the construction following termination of the EPC contract. Accoya® Arnhem plant fourth reactor on track to be operational Q4 FY22. Accoya® USA JV on track for investment decision in summer 2021 following successful Accsys’ €35m net capital raise in May 2021 to fund Accsys’ equity share of JV. Living our purpose of “Changing wood to change the world”: formal sustainability strategy first Sustainability Report published during the year and increased operational safety commitments. Notes: Accoya® Manufacturing margin is defined as Accoya® segmental underlying gross profit (excluding Licence income and marketing services) divided by Accoya® segmental revenue (excluding Licence income and marketing services) (See note 3 to the financial statements) Underlying EBITDA is defined as Operating profit/(loss) before Exceptional items and other adjustments, depreciation and amortisation, and includes the Group’s attributable share of our USA joint venture’s underlying EBITDA. (See note 3 to the financial statements). Underlying EBIT is defined as Operating profit/(loss) before Exceptional items and other adjustments and includes the Group’s attributable share of our USA joint venture’s underlying EBIT. (See note 3 to the financial statements) Net debt is defined as short term and long-term borrowings (including lease obligations) less cash and cash equivalents. (See note 29 to the financial statements). Group operating cashflow is Cash inflows from operating activities before changes in working capital and exceptional items. Accsys has set a ‘5x’ production capacity growth target, to achieve 200k m3 equivalent production capacity by 2025, from the 2019 level of 40k m3 ROBERT HARRIS, CEO COMMENTED: “This has been a year of clear progress for the Group. We managed the initial challenges presented by the pandemic and have delivered growth in revenues, profits and margins, alongside progress on our sustainability agenda; Changing Wood to Change the World. We have also increased our commitment to safety and the wellbeing of our people and the environment during the year. As focus on sustainability grows, demand continues to exceed supply for our sustainable products and underpins our strategic growth plans which progressed well during the year. We are finalising the construction of our Hull plant and the fourth reactor at Arnhem, which will double our capacity as a Group. Additionally, following the close of our year, we announced a successful equity raise to support our joint venture with Eastman Chemical Company to build an Accoya® USA plant. This raise was significantly oversubscribed and will allow us to address the substantial North American market where demand continues to grow. We expect revenue growth as the additional capacity at Arnhem becomes operational. Further to our update earlier this month regarding the status of the Hull plant, we are taking over the project and are evaluating the most effective way to complete the construction following termination of the EPC contract, and are in the process of validating the remaining works, costs and timeline for completing the project. Group overheads will increase next year given the investment in our organisation for growth and ahead of the planned Hull plant start-up. Longer term, for Accsys as a whole, we expect to continue to achieve improving profitability as each step in our growth journey allows us to significantly increase the level of sales and take advantage of economies of scale associated with higher operating levels. As the focus on the carbon footprint of the built environment continues to sharpen, we expect significant demand for our high-performance and sustainable products and remain on track to meet this demand through increasing our capacity fivefold by 2025. I remain confident in the significant long-term growth opportunities ahead and in our ability to execute our strategy in pursuit of sustainable growth for our world-leading high performance, sustainable construction products.”
Als ik het zo snel lees is het perfect!
Cijfers prima, zoals verwacht. Helaas nog geen nieuws over het Hull project
Theoretische openingsprijs 1,938 Hopelijk kunnen we vandaag eindelijk die 2 euro eens doorbreken! I strongly believe that Accsys is well positioned to seize the large global market opportunity for its products and its 2025 ‘5x’ increased production capacity target. Vervijfvoudigen! Erg ambitieus Gister nog wat bij gekocht. Ik verwacht dat dit een mooi aandeel is voor de toekomst. Succes !!
Accsys ziet resultaten flink aantrekken Bericht delen via: Kopieer link Door ABM Financial News op dinsdag 22 juni 2021 Views: 16 Beeld: Accsys (ABM FN-Dow Jones) Accsys heeft in het afgelopen boekjaar de resultaten flink zien aantrekken. Dit bleek dinsdagochtend uit voorlopige cijfers van de houtveredelaar met een fabriek in Arnhem. In het afgelopen boekjaar, dat liep tot 31 maart, bedroeg de onderliggende omzet 99,8 miljoen euro tegen 90,9 miljoen euro een jaar eerder. De verkoopvolumes stegen met 4,5 procent, waarbij Accsys wees op een snel herstel na de impact van de coronacrisis in het eerste kwartaal. De brutowinst steeg van 27,5 naar 33,1 miljoen euro, terwijl de EBITDA aantrok van 7 miljoen euro een jaar eerder tot 10,1 miljoen euro afgelopen boekjaar. Accsys profiteerde onder meer van hogere verkoopprijzen. Onder de streep restte een onderliggende winst van 1,1 miljoen euro. Een jaar eerder werd nog een verlies geboekt van 2,2 miljoen euro. Ook de schuldpositie verbeterde aanzienlijk. Eind maart 2020 had Accsys nog 25,2 miljoen euro aan schulden. Per 31 maart 2021 bedroegen de schulden nog maar 12,2 miljoen euro. De operationele kasstroom steeg met 61 procent als gevolg van de significante marktvraag, die ook nog eens hoger ligt dan de huidige productiecapaciteit. Accsys zegt op schema te liggen om de doelen voor 2025 te halen. De productiecapaciteit moet tegen die tijd zijn vervijfvoudigd. CEO Robert Harris verwacht een aanhoudende omzetgroei, nu er extra productiecapaciteit in Arnhem is bijgekomen. Ook voor de langere termijn verwacht de topman een aantrekkende winstgevendheid. Wel waarschuwde de topman dat de overhead komend jaar stijgt, door investeringen in groei.
jatochnietdan schreef op 22 juni 2021 08:37 :
Theoretische openingsprijs 1,938
Hopelijk kunnen we vandaag eindelijk die 2 euro eens doorbreken!
I strongly believe that Accsys is well positioned to seize the large global market opportunity for its products and its 2025 ‘5x’ increased production capacity target.
Vervijfvoudigen! Erg ambitieus
Gister nog wat bij gekocht.
Ik verwacht dat dit een mooi aandeel is voor de toekomst.
Succes !!
tot nu toe niet gezien dat theoretische openingsprijs bijgesteld is . Freeze?
alida1 schreef op 22 juni 2021 08:50 :
[...]
Momenteel heel weinig in de bied
winst 1,1 miljoen. nou nou
Theoretische openingsprijs 1,98
Daar is de 2! En nu doordenderen
Pjotr schreef op 22 juni 2021 08:52 :
winst 1,1 miljoen. nou nou
Ja de winst was 1,1 miljoen Euro. Niet veel misschien maar je lees niet anders dat grondstoffen waaronder ook hout enorm in prijs stijgen op dit moment. Ik verwacht dan ook zeker dat ook Accsys hier enorm van gaat profiteren en dat de winst hierdoor flink gaat stijgen.
We gaan nog veel hoger! Yeah
Bijkopen en 5 jaar op de plank leggen
''We have lift-off'' have a nice day
Uit het pb kun je opmaken dat komend boekjaar veel beter gaat worden (geen corona, meer vragen dan aanbod, productiecapaciteit stijgt, aantrekkende marges). Ik ben wel benieuwd naar 'Hull'...
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)